VPN Plus+ ExclusiveFecal microbiota transplantation study results in fewer pooch paunchesOctober 20, 2022Now that the clinical phase of this trial is complete, the real work of data analysis begins. A first-of-its-kind multi-omics approach will evaluate the intestinal microbiota of participating dogs through DNA sequencing and measuring metabolites to assess functional changes in the gut. Winston notes even if FMT does not directly speed up weight loss, it could still have a powerful impact on health.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Canine epilepsy studies score fundingNovember 2, 2021In honor of Epilepsy Awareness Month, the AKC Canine Health Foundation has awarded grants totaling more than $375,000.
VPN Plus+ ExclusiveDeveloping a better working dogAugust 26, 2021Veterinary professionals are integral to maintaining and optimizing the health of working dogs in their care. Due to the emotional and financial investment behind every working dog, veterinary support for research into the development of successful working dogs is also key.
Genetic test resource helps breed healthier dogsSeptember 16, 2020AKC Canine Foundation has published a white paper to help veterinarians interpret genetic test results.
$2.1 million in grants fund canine cancer researchMarch 3, 2020Early-stage lymphoma, appendicular osteosarcomas, and the detection of degenerative myelopathy are among the research topics selected to receive funding from the AKC Canine Health Foundation (CHF).
AKC Canine Health Foundation funds clinical trial to study cannabidiol in treating drug-resistant epilepsy in dogsSeptember 14, 2017By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side effects of currently available drugs are not tolerated, according to the organization. To that, the CHF has announced the beginning a major clinical trial to study the use of cannabidiol to treat drug resistant epilepsy in dogs. Stephanie McGrath, MS, DVM, DACVIM (Neurology), at Colorado State University's College of Veterinary Medicine and Biomedical Sciences, will lead "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy." According to Dr. McGrath, up to 30 percent of dogs receiving standard anti-epileptic therapy remain uncontrolled for their seizures, and the side effects of the antiepileptic drugs are often unacceptable. CBD, a nonpsychotropic component of the Cannabis sativa plant, has been shown to have anticonvulsant properties; this randomized, double-blinded, placebo-controlled, crossover clinical trial study will be utilized to prove its effectiveness, she stated. "The timeliness and importance of research into the role of cannabis in …
AKC Canine Health Foundation awards research grant to study bloatJune 12, 2017The AKC Canine Health Foundation (CHF) awarded a new research grant to Michael Harkey, Ph.D., of the Fred Hutchinson Cancer Research Center to study the genetics of gastric dilatation volvulus (GDV) and its association with specific genes of the immune system and gut bacteria.
